• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Alma Lasers acquires Quantel Derma

Article

Alma Lasers has signed an agreement to acquire the assets of Quantel Derma, (formerly known as Wavelight), a France- and Germany-based developer of laser technologies for dermatologists. The transaction was expected to be finalized in July.

Alma Lasers has signed an agreement to acquire the assets of Quantel Derma, (formerly known as Wavelight), a France- and Germany-based developer of laser technologies for dermatologists. The transaction was expected to be finalized in July.

Under the terms of the agreement, Alma Lasers will acquire all of Quantel Derma's assets from the Quantel Group, which is a publicly traded company on the Paris Stock Exchange. Alma Lasers reportedly will integrate Quantel Derma's products within its current portfolio and provide support and service to all existing Quantel Derma customers.

"This is an important milestone in executing Alma Lasers’ long-term strategic plan," said Ziv Karni, Ph.D., Alma Lasers’ founder and CEO. “The acquisition of Quantel Derma brings to Alma Lasers a large, well-respected and high-quality portfolio of FDA- and CE-cleared lasers."

Said Alain de Salaberry, chairman of the Quantel Group, "The sale of Quantel Derma to Alma Lasers will allow us to better focus our resources on industrial and ophthalmic lasers. We are honored that Alma Lasers has chosen our dermatological division, as it’s a clear sign of the high quality found in all of Quantel's laser products."

Related Videos
© 2024 MJH Life Sciences

All rights reserved.